Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Therapeutic responses to clindamycin in combination with quinine were assessed in adult Thai patients with uncomplicated multidrug-resistant Plasmodium falciparum malaria. In total 204 patients were randomized to receive a 7-day oral treatment regimen of quinine (Q 7 ) either alone ( n = 68), in combination with clindamycin (Q 7 C 7 ; n = 68), or in combination with tetracycline (Q 7 T 7 ; n = 68). All patients had uncomplicated recoveries with no serious adverse effects. Fever clearance times for both of the two combination regimens (median of 47 h and range of 8 to 120 h for Q 7 C 7 and median of 36 h and range of 8 to 117 h for Q 7 T 7 ) were significantly shorter than that for the Q 7 -only regimen (median, 56; range, 4 to 152 h) ( P = 0.002). Parasite clearance times (overall mean ± standard deviation, 78 ± 23 h) were not significantly different between the three treatment groups ( P = 0.98). The cure rates assessed at 28 days of follow-up were 100% for Q 7 C 7 and 98% for Q 7 T 7 , whereas the cure rate was 87% for the Q 7 -only regimen ( P ≤ 0.04). Clindamycin in combination with quinine is a safe and effective treatment for multidrug-resistant P. falciparum malaria. This combination may be of particular value in children and pregnant women, in whom tetracyclines are contraindicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citation
Cited by
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,007
Treatment of Malaria in the United States: A Systematic Review
Griffith, K. S., Lewis, L. S., Mali, S., & Parise, M. E. (2007) · JAMA · doi:10.1001/jama.297.20.2264 · Cited by 238
“Quinine has a rapid onset of action and, in combination with either tetracycline, doxycycline, or clindamycin, has been shown to be a very efficacious treatment option for P falciparum infections acquired in regions with chloroquineresistant strains.(52-73) For P falciparum infections acquired in Southeast Asia, a 7-d…”
BackgroundRatcliff, A., Siswantoro, H., Kenangalem, E., Wuwung, M., Brockman, A., Edstein, M. D., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E., et al. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.06.008 · Cited by 172
“These figures compare ith 438 for CQ-sensitive P. vivax isolates from Thailand Pukrittayakamee et al., 2000a) and 1000 for CQ-sensitive . falciparum isolates (White et al., 1989).”
InfluentialMcGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90106-3 · Cited by 114
Self-citation
Metadata
- Authors
- Pukrittayakamee, S., Chantra, A., Vanijanonta, S., Clemens, R., Looareesuwan, S., & White, N. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-09
- Volume
- 44
- Issue
- 9
- Pages
- 2395-2398
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2145933399
- Cited by
- 73
- References
- 1
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.